Independent Research Grants
The AACR and its partners support independent investigators at all career stages, enabling promising researchers to embark on transformative projects that are expected to lead to significant advances in the field.
Independent research grants are categorized as individual or team science.
Please find our active Individual Research Grants below:
- AACR-Bayer Innovation and Discovery Grants
Duration: one year.
Additional detail: in addition to research support, grant recipients receive opportunities for mentoring from Bayer scientists.
- AACR-Bristol Myers Squibb Midcareer Female Investigator Grant
Duration: three years. Research focus: immuno-oncology.
- AACR-Novocure Tumor Treating Fields Research Grants
Duration: two years.
- AACR-PLGA Fund at the Pediatric Brain Tumor Foundation Research Grant to Optimize Drug Dosing Strategies for Pediatric LGA/LGG Patients
Duration: two years.
Research focus: effective dosing parameters for treating children with PLGA brain tumors.
Additional detail: projects must be implemented by a collaborative research team, composed of one principal investigator and at least one collaborator from a different institution.
- AACR-The Mark Foundation for Cancer Research “Science of the Patient” (SOP) Grants
Additional detail: these grants fund projects that emphasize the interplay of host physiological systems with the tumor and tumor microenvironment.
- Neuroendocrine Tumor Research Foundation-AACR Grant
Duration: two years.
- SU2C Innovative Research Grants
Duration: three years.
Additional detail: novel, high-risk, high-reward research that have significant potential for translational application.
Please find our active Team Science Research Grants below:
- Pancreatic Cancer Action Network-AACR Research Acceleration Network Grants
Additional detail: these grants support collaborative research that have the potential to double the survival of pancreatic cancer by 2020. Funded research needs to include a clinical component aimed at improving the detection or treatment of pancreatic cancer.
- Pancreatic Cancer Collective New Therapies Challenge Research Grants Additional detail: two-step approach that provided initial, short-term funding to a number of applicants (Round 1), followed by additional funding for a subset of Round 1-funded Teams (Round 2) for clinical studies.
- SU2C Catalyst® Team Grants
Duration: three years.
Additional detail: these grants provide a mechanism through which industry supports academic scientists to conduct collaborative research projects that have the potential to accelerate the development of new treatments and, where possible, combination therapies with the goal of delivering significant benefits for patients.
- SU2C Dream Team and Research Team Grants
Duration: three-four years.
Additional detail: these grants address critical problems in patient care. and are designed to deliver near-term patient benefit (no later than within two to three years from the start of the grant) through investigation by multidisciplinary teams.
- SU2C Phillip A. Sharp Awards
Duration: two years.
Additional detail: these grants are available to members of the SU2C scientific community who are present at the annual SU2C Scientific Summit, to explore synergistic and innovative collaborations that enhance the SU2C mission to accelerate the development of new cancer treatments.